XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (45,461,664) $ (5,061,314)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 14,113,730 4,620,725
LO2A write offs 23,963,050
Operating lease expense 491,782
Share of loss of equity accounted investments 368,426
Interest on convertible notes satisfied by issue of notes 860,399
Loss on purchase in Innovation Property Management, LLC 28,102
Foreign exchange loss/(gain) 1,026,770 (825,731)
Loss on sale of shares 72,623
Share based payments 22,491,100
Gain on disposal of fixed assets (283,434)
Acquisition of Wize Pharma Inc 5,436,541
Buyout of non-controlling interest (150,766)
Change in assets and liabilities    
Trade and other receivables (4,991,635) 35,257
Other current assets (847,872) 246,289
Trade and other payables 5,864,742 771,575
Net cash provided by operating activities 22,953,792 (185,097)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of property and equipment (76,804,866) (5,507,792)
Payments for trademarks (11,190)
Purchase of investment shares (767,850)
Proceeds from sales of property and equipment 694,181
Payment of fixed asset deposits (51,369,216)  
Acquisition of Luna Squares LLC, net of cash acquired (17,854)
Net cash used in investing activities (128,247,751) (5,536,836)
CASH FLOWS FROM FINANCING ACTIVITES    
Proceeds from common share issuances 85,102,014 6,239,987
Proceeds from convertible notes 20,301,427
Payments of capital issuance costs (6,122,429) (24,959)
Proceeds from borrowings 14,269,454
Proceeds from shareholder loans 21,298
Repayment of lease liabilities (230,962) (6,444)
Payments of borrowings (3,465,044)
Net cash provided by financing activities 109,854,460 6,229,882
Effect of exchange rate changes on cash and cash equivalents (206,039) 25,572
Net increase in cash and cash equivalents 4,354,462 533,521
Cash and cash equivalents at beginning of period 1,112,811 579,290
Cash and cash equivalents at end of period $ 5,467,273 $ 1,112,811